KSM-66® Ashwagandha reduces cortisol by approximately 27.9% in published RCTs. Complete guide to the mechanism, evidence and optimal protocol for cortisol management.
KSM-66® Ashwagandha at 600mg daily reduces serum cortisol by approximately 27.9% in published double-blind, placebo-controlled trials. The mechanism involves modulation of the HPA (hypothalamic-pituitary-adrenal) axis — the central stress response system. Effects accumulate over 8-12 weeks of consistent use.
The hypothalamic-pituitary-adrenal (HPA) axis is the body's central stress response system. When the brain perceives stress, the hypothalamus releases CRH → the pituitary releases ACTH → the adrenal glands secrete cortisol. Chronic stress produces chronically elevated cortisol — associated with anxiety, sleep disruption, weight gain and testosterone suppression.
KSM-66® Ashwagandha's withanolides act as adaptogenic modulators of the HPA axis — reducing the amplitude of the cortisol stress response without suppressing the cortisol system entirely. This produces a calmer baseline cortisol level while maintaining appropriate stress response capacity.
Cortisol and testosterone share biosynthetic precursors — specifically pregnenolone. Chronic cortisol elevation diverts precursors from testosterone synthesis. Reducing cortisol via KSM-66® therefore supports testosterone production through the reduction of this competitive inhibition.